NLP to Aid in the Evaluation and Diagnosis of FGIDs | MicrobiomeTrials← Back to trialsNCT05501028
NLP to Aid in the Evaluation and Diagnosis of FGIDs
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2018-08-09Est. Completion: 2026-12
Enrollment target: 700 participants Locations- Massachusetts General Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Pancreatitis, Chronic; Diabetes; Transplant
Patients with severe chronic pancreatitis may be candidates to have their pancreas removed and their islets transplanted…
Minneapolis, United StatesCompleted Jul 1, 2023
Scleroderma, Systemic
The goal of this clinical trial is to evaluate whether anti-CD19 CAR T-cell therapy can improve disease activity in adul…
Lille, FranceEst. completion Aug 1, 2026
Phase 2
Recruiting
Breast CancerGastric CancerEsophageal CancerGastroesophageal CancerColorectal CancerEndometrial CancerNon-small Cell Lung CancerOvarian CancerUrothelial CarcinomaSalivary Gland CancerPancreatic CancerHER-2 Protein Overexpression
The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with p…
Prescott, United StatesEst. completion Dec 31, 2026